Li W, Chen Y, Zhang X, et al
Beyond Ozempic breath: A U of T Dentistry researcher examines GLP-1s and oral health By Diane Peters At his practice in North York, U of T Dentistry associate professor Aviv Ouanounou often treats patients with complex health conditions such as diabetes, cardiovascular disease and obesity
This is often due to lifestyle factors, medication side effects, and the stress brought on by psychiatric illnesses
GLP-1 medications, by contrast, are designed for long-term use and are often continued indefinitely as part of an ongoing weight management plan
Overweight and obesity in adults NHS
The key question is not whether $225 per month is cheap